Pancreatic Cancer Research

Preprint2022

Nuclear-anchored FGFR regulates cell proliferation and cisplatin resistance in pancreatic ductal adenocarcinoma

Published
5 August 2022
Citations
0
Type
Preprint
License
cc by

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract cc by

Background: In natural physiological conditions, FGF is a pleiotropic growth factor with multiple bio-activities and FGF/FGFR system has many important biological functions and roles. Interestingly, more and more evidences show that FGF/FGFR system plays an important role in the occurrence and development of pancreatic ductal adenocarcinoma. Methods In our study, we explored the cellular characteristics of FGF/FGFR system in pancreatic ductal adenocarcinoma cells. In addition, we also investigated the relationship between nuclear localized FGF/FGFR and cisplatin resistance. A series of experimental techniques including indirect immunofluorescence, Western-blot and ELISA were used to analyze the cellular characteristics of FGF/FGFR. We systematically assessed the cell behavior of IGF-1/IGF-1R in the Pancreatic ductal adenocarcinoma cell model. Results We have three main findings: First, we found that IGF-1R could transport into the cell nuclei of Pancreatic ductal carcinoma cell, and the nuclear-localized FGF/FGFR was closely related to the proliferation of Pancreatic ductal carcinoma cells. Additionally, we also found that the nuclear-localized FGF/FGFR might be closely associated with cisplatin resistance in pancreatic ductal adenocarcinoma, this may be a potential mechanism of cisplatin resistance; Secondly, we found that the nuclear-localized FGF/FGFR showed a positive correlation with the intensity of AKT signaling. Conclusions Taken together, this work lays the foundation for further research on the relationship between the nuclear FGF/FGFR and the pancreatic ductal adenocarcinoma development or cisplatin resistance in pancreatic ductal adenocarcinoma.